 IBTimes.co.uk |
AstraZeneca wins temporary block on Actavis asthma drug
4-traders (press release) AstraZeneca (>> AstraZeneca plc) has secured a temporary block on U.S. sales of generic copies of its Pulmicort Repsules asthma drug by Actavis (>> Actavis Inc). AstraZeneca (>> AstraZeneca plc) has secured a temporary block on U.S. sales of generic … AstraZeneca Loses US Patent Protection for Asthma Drug AstraZeneca's Kid Asthma Drug Patent Invalid, Judge Says Blow for AstraZeneca in USA over asthma drug patents |
View full post on asthma – Google News